Skip to main content Skip to navigation
Monday, April 3 @4:10 pm
Chemistry Departmental Seminar – Prof. Anna Schwendeman
Workshop / Seminar
WSU Pullman - Fulmer Hall

Research focus is on design of synthetic high density lipoprotein (HDL) nanoparticles for treatment of cardiovascular disease. We discover novel ApoA-I mimetic peptides, explore biophysics of peptide-lipid interactions and optimize HDL compositions for interaction with specific cellular receptors, transporters and enzymes involved in RCT. We examine sHDL biodistribution, pharmacokinetics and pharmacodynamic properties.

Tuesday, April 4 @12:30 pm
Organic Chemistry Seminar – Anunay Pulukuri, Chemistry Graduate Student
Workshop / Seminar
WSU Pullman - Fulmer Hall

Multidrug Resistant (MDR) cancers attenuate chemotherapeutic efficacy through drug efflux via ABC (ATP-Binding Cassette) transporters, including P-glycoprotein 1 (P-gp or ABCB1/MDR1). Conversely, Toll-Like Receptor (TLR) agonist immunotherapies modulate activity of tumor-infiltrating immune cells in local proximity to cancer cells and could benefit from the enhanced drug efflux in MDR cancers. However, the effect of acquired drug resistance on TLR agonist efflux is largely unknown.

Friday, April 21 @4:10 pm
Physical Chemistry Seminar – Prof. Anjali Sharma, Department of Chemistry
Workshop / Seminar
WSU Pullman - Fulmer Hall

Speaker: Prof. Anjali Sharma, Washington State University, Department of Chemistry

Title: Novel Dendritic Nanostructures for Cell-Targeted Drug Delivery

Abstract: Poor transport of therapeutics across various physiological barriers limits the development of effective treatments for central nervous system (CNS) disorders, cancer and beyond. The primary clinical challenge in…